No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Amgen Launches First US Eculizumab Biosimilar with Interchangeability
On 5 March 2025, Generics Bulletin reported that Amgen has launched Bkemv® (eculizumab-aeeb) in the US as the first available interchangeable biosimilar to Alexion’s Soliris®…